Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Ambatipudi, Srikant ^a   Gerstung, Moritz ^b,c   Gowda, Ravindra ^a   Pai, Prathamesh ^a   Borges, Anita M ^d   Schäffer, Alejandro A ^e   Beerenwinkel, Niko ^b,c   Mahimkar, Manoj B ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b ETH ZURICH   (Switzerland)

^c SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^d SL Raheja Hospital   (India)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 19P; CHROMOSOME 3Q; CHROMOSOME 7P; CHROMOSOME 8Q; CHROMOSOME ARM; CHROMOSOME LOSS; CHROMOSOME MARKER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE NUMBER; GINGIVA TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OUTCOME ASSESSMENT; PRIMARY TUMOR; PROGNOSIS; SURVIVAL TIME; TONGUE CANCER; CELL CULTURE; CHROMOSOME 11; CHROMOSOME ABERRATION; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETICS; HELA CELL; HUMAN GENOME; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VALIDATION STUDY;

TUMOR MARKER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HELA CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VALIDATION STUDIES AS TOPIC;

EID: 79952232345     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017250     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
2. Lippman SM, Hong WK, (2001) Molecular markers of the risk of oral cancer. N Engl J Med 344: 1323-1326.
3. Akervall J, (2006) Genomic screening of head and neck cancer and its implications for therapy planning. Eur Arch Otorhinolaryngol 263: 297-304.
4. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, et al. (1997) Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407.
5. Kallioniemi A, (2008) CGH microarrays and cancer. Curr Opin Biotechnol 19: 36-40.
6. Frohling S, Dohner H, (2008) Chromosomal abnormalities in cancer. N Engl J Med 359: 722-734.
7. Snijders AM, Schmidt BL, Fridlyand J, Dekker N, Pinkel D, et al. (2005) Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 24: 4232-4242.
8. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL, (2005) Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561-7567.
9. Liu CJ, Lin SC, Chen YJ, Chang KM, Chang KW, (2006) Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog 45: 721-731.
10. Nakamura E, Kozaki K, Tsuda H, Suzuki E, Pimkhaokham A, et al. (2008) Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma. Cancer Sci 99: 1390-1400.
11. Nakaya K, Yamagata HD, Arita N, Nakashiro KI, Nose M, et al. (2007) Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array. Oncogene 26: 5300-5308.
12. Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, et al. (2007) PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation. Oncogene 26: 7921-7932.
13. Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, et al. (2010) Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 49: 9-16.
14. Garnis C, Coe BP, Zhang L, Rosin MP, Lam WL, (2004) Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas. Oncogene 23: 2582-2586.
15. Järvinen AK, Autio R, Kilpinen S, Saarela M, Leivo I, et al. (2008) High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer 47: 500-509.
16. Paterson IC, Eveson JW, Prime SS, (1996) Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral Oncol 32B: 150-153.
17. Shah JP, Singh B, (2006) Keynote comment: why the lack of progress for oral cancer? Lancet Oncol 7: 356-357.
18. Klussmann JP, Mooren JJ, Lehnen M, Claessen SM, Stenner M, et al. (2009) Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15: 1779-1786.
19. Gillison ML, (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31: 744-754.
20. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, et al. (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100: 261-269.
21. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ, (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76 (Pt 4): 1057-1062.
22. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, et al. (1985) Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 1350-1354.
23. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36: 949-951.
24. Smith ML, Marioni JC, Hardcastle TJ, Thorne NP, (2006) snapCGH: Segmentation, Normalization and Processing of aCGH Data User's Guide, Bioconductor.
25. Venkatraman ES, Olshen AB, (2007) A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 23: 657-663.
26. Taylor BS, Barretina J, Socci ND, Decarolis P, Ladanyi M, et al. (2008) Functional copy-number alterations in cancer. PLoS One 3: e3179.
27. la Cour JM, Hoj BR, Mollerup J, Simon R, Sauter G, et al. (2008) The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability. Mol Oncol 1: 431-439.
28. Ting L, Jun H, Junjie C, (2010) RAD18 lives a double life: Its implication in DNA double-strand break repair. DNA Repair (Amst) 9: 1241-1248.
29. Shu ST, Sugimoto Y, Liu S, Chang HL, Ye W, et al. (2010) Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. Anticancer Res 30: 1937-1946.
30. Scully C, Field JK, Tanzawa H, (2000) Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 36: 311-327.
31. Kohno T, Otsuka A, Girard L, Sato M, Iwakawa R, et al. (2010) A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. Genes Chromosomes Cancer 49: 342-352.
32. Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, et al. (2009) The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A 106: 9435-9440.
33. Parikh RA, White JS, Huang X, Schoppy DW, Baysal BE, et al. (2007) Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 46: 761-775.
34. Gollin SM, (2001) Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23: 238-253.
35. Jin C, Jin Y, Gisselsson D, Wennerberg J, Wah TS, et al. (2006) Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma. Cytogenet Genome Res 115: 99-106.
36. Akervall J, Kurnit DM, Adams M, Zhu S, Fisher SG, et al. (2004) Overexpression of cyclin D1 correlates with sensitivity to cisplatin in squamous cell carcinoma cell lines of the head and neck. Acta Otolaryngol 124: 851-857.
37. Huang X, Gollin SM, Raja S, Godfrey TE, (2002) High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A 99: 11369-11374.
38. Huang X, Godfrey TE, Gooding WE, McCarty KS Jr, Gollin SM, (2006) Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 45: 1058-1069.
39. Reshmi SC, Roychoudhury S, Yu Z, Feingold E, Potter D, et al. (2007) Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification. Cytogenet Genome Res 116: 46-52.
40. Jin Y, Hoglund M, Jin C, Martins C, Wennerberg J, et al. (1998) FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer 22: 312-320.
41. Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM, (2009) Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 48: 569-582.
42. Saucedo LJ, Edgar BA, (2007) Filling out the Hippo pathway. Nat Rev Mol Cell Biol 8: 613-621.
43. Liu AM, Xu MZ, Chen J, Poon RT, Luk JM, (2010) Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin Ther Targets 14: 855-868.
44. Ding X, He Z, Zhou K, Cheng J, Yao H, et al. (2010) Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. J Natl Cancer Inst 102: 1052-1068.
45. Chigurupati S, Venkataraman R, Barrera D, Naganathan A, Madan M, et al. (2010) Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness. Cancer Res 70: 418-427.
46. Konishi H, Takahashi T, Kozaki K, Yatabe Y, Mitsudomi T, et al. (1998) Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene 17: 2095-2100.
47. Goi T, Takeuchi K, Katayama K, Hirose K, Yamaguchi A, (2002) Mutations of rabphillin-3A-like gene in colorectal cancers. Oncol Rep 9: 1189-1192.
48. Smith JS, Tachibana I, Allen C, Chiappa SA, Lee HK, et al. (1999) Cloning of a human ortholog (RPH3AL) of (RNO)Rph3al from a candidate 17p13.3 medulloblastoma tumor suppressor locus. Genomics 59: 97-101.
49. Benjamini Y, Hochberg, Y, (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc B 57: 289-300.